Literature DB >> 9613267

Intrathecal diamorphine for analgesia after caesarean section. A dose finding study and assessment of side-effects.

M C Kelly1, U A Carabine, R K Mirakhur.   

Abstract

Eighty women undergoing elective Caesarean section under spinal anaesthesia using hyperbaric bupivacaine 0.5% were randomly allocated to receive, in addition, intrathecal diamorphine 0.125, 0.25 or 0.375 mg or saline. Postoperative morphine requirements, measured using a patient-controlled analgesia system, were reduced in a dose-dependent manner by diamorphine. Pain scores were significantly lower at 2 and 6 h following the two larger doses of diamorphine. Less supplemental analgesia was required intra-operatively if intrathecal diamorphine had been given. The incidences of vomiting and pruritus were also dose-related. No respiratory rates of less than 14 breath.min-1 were recorded and the incidence of oxygen saturation readings less than 95% and 90% did not differ between groups. There were no adverse neonatal effects. Intrathecal diamorphine in the present study was found to be safe in doses of up to 0.375 mg following Caesarean section. However, minor side-effects were frequently observed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613267     DOI: 10.1046/j.1365-2044.1998.00307.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Intravenous butorphanol administration reduces intrathecal morphine-induced pruritus after cesarean delivery: a randomized, double-blind, placebo-controlled study.

Authors:  Zhen Wu; Mingjian Kong; Ning Wang; Roderick J Finlayson; Q H De Tran
Journal:  J Anesth       Date:  2012-06-07       Impact factor: 2.078

Review 2.  Effects of intrathecal opioids on cesarean section: a systematic review and Bayesian network meta-analysis of randomized controlled trials.

Authors:  Hiroyuki Seki; Toshiya Shiga; Takahiro Mihara; Hiroshi Hoshijima; Yuki Hosokawa; Shunsuke Hyuga; Tomoe Fujita; Kyotaro Koshika; Reina Okada; Hitomi Kurose; Satoshi Ideno; Takashi Ouchi
Journal:  J Anesth       Date:  2021-08-02       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.